CALL/PFIZER INC/30/0.1/20.09.24 Share Price

Warrant

DE000GQ5XD19

Real-time BOERSE MUENCHEN 05:55:13 27/06/2024 pm IST
0.039 EUR -4.88% Intraday chart for CALL/PFIZER INC/30/0.1/20.09.24
Current month-50.60%
1 month-59.00%
Date Price Change
27/24/27 0.039 -4.88%
26/24/26 0.041 -19.61%
25/24/25 0.051 -5.56%
24/24/24 0.054 +22.73%
21/24/21 0.044 -13.73%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 05:55 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Goldman Sachs
WKN GQ5XD1
ISINDE000GQ5XD19
Date issued 22/09/2023
Strike 30 $
Maturity 20/09/2024 (85 Days)
Parity 10 : 1
Emission price 0.44
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.563
Lowest since issue 0.032
Delta0.23x
Omega 15.49
Premium10.89x
Gearing67.43x
Moneyness 0.9140
Difference Strike 2.58 $
Difference Strike %+8.60%
Spread 0.01
Spread %23.26%
Theoretical value 0.0380
Implied Volatility 24.30 %
Total Loss Probability 80.26 %
Intrinsic value 0.000000
Present value 0.0380
Break even 30.41 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42 USD
Average target price
31.92 USD
Spread / Average Target
+16.39%
Consensus